Scheduled and Breakthrough Opioid Use for Cancer Pain in an Inpatient Setting at a Tertiary Cancer Hospital.

MLA

Rozman de Moraes, Aline, et al. “Scheduled and Breakthrough Opioid Use for Cancer Pain in an Inpatient Setting at a Tertiary Cancer Hospital.” Current Oncology, vol. 31, no. 3, Mar. 2024, pp. 1335–47. EBSCOhost, https://doi.org/10.3390/curroncol31030101.

APA

Rozman de Moraes, A., Erdogan, E., Azhar, A., Reddy, S. K., Lu, Z., Geller, J. A., Graves, D. M., Kubiak, M. J., Williams, J. L., Wu, J., Bruera, E., & Yennurajalingam, S. (2024). Scheduled and Breakthrough Opioid Use for Cancer Pain in an Inpatient Setting at a Tertiary Cancer Hospital. Current Oncology, 31(3), 1335–1347. https://doi.org/10.3390/curroncol31030101

Chicago

Rozman de Moraes, Aline, Elif Erdogan, Ahsan Azhar, Suresh K. Reddy, Zhanni Lu, Joshua A. Geller, David Mill Graves, et al. 2024. “Scheduled and Breakthrough Opioid Use for Cancer Pain in an Inpatient Setting at a Tertiary Cancer Hospital.” Current Oncology 31 (3): 1335–47. doi:10.3390/curroncol31030101.